GAAP net income was $17,000,000 for the quarter. GAAP results for the Q3 of 2024 included $117,000,000 in amortization of intangibles, dollars 36,000,000 in expenses related to the Web Health combination and integration, dollars 23,000,000 in share based compensation expense, dollars 2,000,000 in step up depreciation, dollars 11,000,000 increase in acquisition contingent consideration, dollars 33,000,000 in net foreign currency losses, dollars 4,000,000 in imputed interest related to the seller's note issued in connection with the combination and a $5,000,000 one time tax expense associated with legal entity restructuring. Our adjusted free cash flow for the quarter was $135,000,000 net of $63,000,000 in capital expenditures. As we stated in the last call, the adjusted free cash flow metric is calculated as free cash flow excluding the impact of changes in the factory program that we assumed and have continued to operate since the WebHelp combination. Adjusted free cash flow was below expectations for the quarter as a result of client collection delays in the month of August, principally in Europe that have been caught up in September and accelerated spending on integration costs.